Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder.
Confirmed relative bioavailability to the reference standard, dose proportional increases in pharmacokinetic exposure, and no food effect Marks final study needed for the upcoming FDA meeting for...
GLEN ALLEN, Va., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing...
GLEN ALLEN, Va., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.08 | -7.27272727273 | 1.1 | 1.28 | 0.9924 | 524175 | 1.10836281 | CS |
4 | -0.08 | -7.27272727273 | 1.1 | 1.28 | 0.9696 | 200805 | 1.08378746 | CS |
12 | 0.05 | 5.15463917526 | 0.97 | 1.28 | 0.9355 | 145532 | 1.06105863 | CS |
26 | -0.46 | -31.0810810811 | 1.48 | 3 | 0.9 | 1470195 | 1.28192406 | CS |
52 | -1.1 | -51.8867924528 | 2.12 | 4.12 | 0.765 | 2383521 | 1.97512939 | CS |
156 | -73.98 | -98.64 | 75 | 78.5 | 0.765 | 1178483 | 6.21191391 | CS |
260 | -38.98 | -97.45 | 40 | 127 | 0.765 | 1020525 | 23.963201 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관